heartbeam.com - BEAT Quick Ratio

HeartBeam, Inc. (BEAT) operates within a narrow segment of ECG monitoring systems, which creates certain regulatory complexities. This price action chart helps track these risks, while the indicator currently stands at 3.47. The developer is protected by the US domestic market, yet remains dependent on chip supplies. Furthermore, sanction restrictions and logistical disruptions hinder the expansion of its cardiac diagnostic solutions into global markets.

For defensive assets, the ability to instantaneously settle short-term debts without liquidating inventory is critical, measured by the sum of cash and accounts receivable. Since HeartBeam, Inc. (BEAT) is currently in the FDA approval stage and has no retail sales, this quick financial stability indicator effectively tracks the venture capital burn rate, signaling the risk of a liquidity gap in the absence of operating income.